Abstract
BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.
| Original language | English |
|---|---|
| Pages (from-to) | 411-418 |
| Number of pages | 8 |
| Journal | Minerva Anestesiologica |
| Volume | 82 |
| Issue number | 4 |
| Publication status | Published - Apr 1 2016 |
Fingerprint
Keywords
- Meloxicam-Spinal injections-Ultrasonography-Brachial plexus neuritis-Chronic pain.
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Cite this
Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam. / Aurini, Lucia; Borghi, Battista; Tognù, Andrea; Rossi, Barbara; Fini, Greta; Fusco, Pierfrancesco; Mosca, Massimiliano; Borghi, Raffaele.
In: Minerva Anestesiologica, Vol. 82, No. 4, 01.04.2016, p. 411-418.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam
AU - Aurini, Lucia
AU - Borghi, Battista
AU - Tognù, Andrea
AU - Rossi, Barbara
AU - Fini, Greta
AU - Fusco, Pierfrancesco
AU - Mosca, Massimiliano
AU - Borghi, Raffaele
PY - 2016/4/1
Y1 - 2016/4/1
N2 - BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.
AB - BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.
KW - Meloxicam-Spinal injections-Ultrasonography-Brachial plexus neuritis-Chronic pain.
UR - http://www.scopus.com/inward/record.url?scp=84969204412&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969204412&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84969204412
VL - 82
SP - 411
EP - 418
JO - Minerva Anestesiologica
JF - Minerva Anestesiologica
SN - 0375-9393
IS - 4
ER -